Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 20, 2016

View Archived Issues

Galapagos updates on progress of cystic fibrosis candidates

Neurotrophic factor-secreting autologous MSCs show promising clinical results in ALS

Acetazolamide counters effects of Klotho hypomorphism on aging

Lilly files NDA for baricitinib for the oral treatment of rheumatoid arthritis

Adimab and iTeos to develop therapeutic antibodies for cancer

Berkeley Lights ships OptoSelect antibody discovery instrument to Amgen

FDA awards fast track designation to ZX-008 for Dravet syndrome

CEVEC and Beckman Research Institute sign collaboration agreement for CAPGT technology

First patient dosed in phase I trial evaluating TP-271

DNAzymes can be used for molecular probes to detect specific bacterial strains

EMA grants orphan drug designation to ARC-AAT

Sunshine Lake Pharma reports anti-HCV NS5B inhibitors

Hybrid Medical's gel H-100 evaluated in patients with Peyronie's disease

Trevena launches phase III clinical program for oliceridine

Pierre Fabre develops antitumor OSW-1 derivatives

Oncaspar receives marketing authorization in the E.U. as combination therapy for ALL

Roche presents ENT1 inhibitors

Profectus BioSciences initiates phase I testing of a vectored Ebola virus vaccine

Takeda develops FFAR2 agonists

Mologen and MD Anderson collaborate in trial of lefitolimod + ipilimumab

Aclaris Therapeutics starts phase III trials for A-101 in seborrheic keratosis

Gilead presents PI3Kdelta inhibitors

NIDA to conduct research on RespireRx compounds to treat drug abuse and addiction

Saniona and Upsher-Smith form neurological drug discovery and development collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...